Regorafenib dose modifications in patients with metastatic colorectal cancer in the phase III CORRECT study

被引：0
|
作者：
Falcone, A. [1 ]
Van Cutsem, E. [2 ]
Sobrero, A. [3 ]
Siena, S. [4 ]
Ychou, M. [5 ]
Lenz, H. J. [6 ]
Yoshino, T. [7 ]
Cihon, F.
Wagner, A. [8 ]
Grothey, A. [9 ]
机构：
[1] Azienda Osped Univ Pisana, UO Oncol Med, Pisa, Italy
[2] Katholieke Univ Leuven Hosp, Louvain, Belgium
[3] Osped San Martino Genova, Genoa, Italy
[4] Osped Niguarda Ca Granda, Milan, Italy
[5] ICM Val dAurelle, Montpellier, France
[6] VSC Norris Comprehens Canc Ctr, Div Med Oncol, Los Angeles, CA USA
[7] Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Chiba, Japan
[8] Bayer Pharma AG, Global Clin Dev Oncol, Berlin, Germany
[9] Mayo Clin, Dept Oncol, Rochester, MN USA
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2360
引用
收藏
页码：S546 / S546
页数：1
相关论文
共 50 条
  • [31] Early modifications of circulating microRNAs levels in metastatic colorectal cancer patients treated with regorafenib
    Marta Schirripa
    Beatrice Borelli
    Romina D’Aurizio
    Simone Lubrano
    Chiara Cremolini
    Gemma Zucchelli
    Carlotta Antoniotti
    Federica Marmorino
    Alessandra Anna Prete
    Sabina Murgioni
    Francesca Bergamo
    Vittorina Zagonel
    Andrea Tuccoli
    Andrea Marranci
    Milena Rizzo
    Lorena Tedeschi
    Letizia Magnoni
    Alfredo Falcone
    Fotios Loupakis
    Laura Poliseno
    The Pharmacogenomics Journal, 2019, 19 : 455 - 464
  • [32] Early modifications of circulating microRNAs levels in metastatic colorectal cancer patients treated with regorafenib
    Schirripa, Marta
    Borelli, Beatrice
    D'Aurizio, Romina
    Lubrano, Simone
    Cremolini, Chiara
    Zucchelli, Gemma
    Antoniotti, Carlotta
    Marmorino, Federica
    Prete, Alessandra Anna
    Murgioni, Sabina
    Bergamo, Francesca
    Zagonel, Vittorina
    Tuccoli, Andrea
    Marranci, Andrea
    Rizzo, Milena
    Tedeschi, Lorena
    Magnoni, Letizia
    Falcone, Alfredo
    Loupakis, Fotios
    Poliseno, Laura
    PHARMACOGENOMICS JOURNAL, 2019, 19 (05): : 455 - 464
  • [33] Phase II study on starting with reduced dose of regorafenib for metastatic colorectal cancer after standard chemotherapy
    Ota, Hirofumi
    Kagawa, Yoshinori
    Ohta, Katsuya
    Miyazaki, Susumu
    Hamabe, Atsushi
    Nishimura, Junichi
    Hata, Taishi
    Matsuda, Chu
    Mizushima, Tsunekazu
    Yamamoto, Hirofumi
    Doki, Yuichiro
    Mori, Masaki
    CANCER SCIENCE, 2018, 109 : 307 - 307
  • [34] A phase II study of dose-escalation of regorafenib for patients with previously treated metastatic colorectal cancer - DEREGULATE study - Trial in progress
    Kawaguchi, K.
    Nishitai, R.
    Manaka, D.
    Ota, T.
    Nishikawa, Y.
    Kudo, R.
    An, H.
    Hamasu, S.
    Konishi, S.
    ANNALS OF ONCOLOGY, 2018, 29
  • [35] Phase II dose titration study of regorafenib for patients with unresectable metastatic colorectal cancer who are progressed after standard chemotherapy
    Kudo, T.
    Kato, T.
    Kagawa, Y.
    Murata, K.
    Ohta, H.
    Noura, S.
    Hasegawa, J.
    Tamagawa, H.
    Ohta, K.
    Ikenaga, M.
    Miyazaki, S.
    Komori, T.
    Nishimura, J.
    Hata, T.
    Matsuda, C.
    Satoh, T.
    Mizushima, T.
    Yamamoto, H.
    Doki, Y.
    Mori, M.
    ANNALS OF ONCOLOGY, 2017, 28
  • [36] Regorafenib for metastatic Colorectal Cancer?
    Bossenmayer, Susanne
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2013, 138 (12) : 563 - 563
  • [37] Regorafenib in metastatic colorectal cancer
    Sartore-Bianchi, Andrea
    Zeppellini, Annalisa
    Amatu, Alessio
    Ricotta, Riccardo
    Bencardino, Katia
    Siena, Salvatore
    EXPERT REVIEW OF ANTICANCER THERAPY, 2014, 14 (03) : 255 - 265
  • [38] Regorafenib for metastatic colorectal cancer
    Andre, Thierry
    Raymond, Eric
    de Gramont, Aimery
    LANCET, 2013, 381 (9877): : 1536 - 1537
  • [39] Regorafenib adjusted dose for Chilean patients with chemoresistant metastatic colorectal cancer: a case series
    Luis Leal, Jose
    Briones, Juan
    Elisa Herrera, Maria
    Muller, Bettina
    Nervi, Bruno
    Mondaca, Sebastian
    ECANCERMEDICALSCIENCE, 2018, 12
  • [40] Regorafenib in Patients With Relapsed Advanced or Metastatic Colorectal Cancer
    Bekaii-Saab, Tanios S.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (09) : 10 - 11
12345